Contents

Current Radiopharmaceuticals, Volume 4 - Number 3

Editorial [Hot Topic: Targeted Alpha Therapy – Part I (Guest Editor: Jorgen Elgqvist)]

, 4(3): 176

Jorgen Elgqvist


DOI: 10.2174/1874471011104030176




Astatine-211: Production and Availability

, 4(3): 177 - 185

Michael R. Zalutsky and Marek Pruszynski


DOI: 10.2174/1874471011104030177




The ARRONAX Project

, 4(3): 186 - 196

Ferid Haddad, Jacques Barbet and Jean-Francois Chatal


DOI: 10.2174/1874471011104030186




Protein Targeting Constructs in Alpha Therapy

, 4(3): 197 - 213

Tove Olafsen, Jorgen Elgqvist and Anna M. Wu


DOI: 10.2174/1874471011104030197




Chemical and Radiochemical Considerations in Radiolabeling with α-Emitting Radionuclides

, 4(3): 214 - 247

D. Scott Wilbur


DOI: 10.2174/1874471011104030214




Pretargeted Radioimmunotherapy with α-Particle Emitting Radionuclides

, 4(3): 248 - 260

Sture Lindegren and Sofia H.L. Frost


DOI: 10.2174/1874471011104030248




Modelling and Dosimetry for Alpha-Particle Therapy

, 4(3): 261 - 265

George Sgouros, Robert F. Hobbs and Hong Song


DOI: 10.2174/1874471011104030261




Alpha-Particle Microdosimetry

, 4(3): 266 - 280

Nicolas Chouin and Manuel Bardies


DOI: 10.2174/1874471011104030266




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science